Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases

Himalian R, Singh SK, Singh MP (2022) Ameliorative role of nutraceuticals on neurodegenerative diseases using the Drosophila melanogaster as a discovery model to define bioefficacy. J Am Nutr Assoc 41(5):511–539. https://doi.org/10.1080/07315724.2021.1904305

Article  CAS  PubMed  Google Scholar 

Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42(3 Pt 1):631–639. https://doi.org/10.1212/wnl.42.3.631

Article  CAS  PubMed  Google Scholar 

Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211. https://doi.org/10.1016/s0197-4580(02)00065-9

Article  PubMed  Google Scholar 

Coyne AN, Zaepfel BL, Zarnescu DC (2017) Failure to deliver and translate-new insights into RNA dysregulation in ALS. Front Cell Neurosci 11:243. https://doi.org/10.3389/fncel.2017.00243

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ, Chen G, Shen T et al. (2017) Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci Transl Med 9 (374). https://doi.org/10.1126/scitranslmed.aag0481

Kritsilis M, S VR, Koutsoudaki PN, Evangelou K, Gorgoulis VG, Papadopoulos D (2018) Ageing, cellular senescence and neurodegenerative disease. Int J Mol Sci 19 (10). https://doi.org/10.3390/ijms19102937

Aleksis R, Oleskovs F, Jaudzems K, Pahnke J, Biverstal H (2017) Structural studies of amyloid-beta peptides: unlocking the mechanism of aggregation and the associated toxicity. Biochimie 140:176–192. https://doi.org/10.1016/j.biochi.2017.07.011

Article  CAS  PubMed  Google Scholar 

Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3(4):519–526. https://doi.org/10.1016/0896-6273(89)90210-9

Article  CAS  PubMed  Google Scholar 

Guo Q, Bin H, Cheng J, Seefelder M, Engler T, Pfeifer G, Oeckl P, Otto M et al. (2018) The cryo-electron microscopy structure of huntingtin. Nature 555(7694):117–120. https://doi.org/10.1038/nature25502

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pearce MMP, Spartz EJ, Hong W, Luo L, Kopito RR (2015) Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat Commun 6:6768. https://doi.org/10.1038/ncomms7768

Article  CAS  PubMed  Google Scholar 

Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK (2019) Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 12:25. https://doi.org/10.3389/fnmol.2019.00025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falcon B, Zhang W, Schweighauser M, Murzin AG, Vidal R, Garringer HJ, Ghetti B, Scheres SHW et al. (2018) Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold. Acta Neuropathol 136(5):699–708. https://doi.org/10.1007/s00401-018-1914-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muntane G, Dalfo E, Martinez A, Ferrer I (2008) Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related alpha-synucleinopathies. Neuroscience 152(4):913–923. https://doi.org/10.1016/j.neuroscience.2008.01.030

Article  CAS  PubMed  Google Scholar 

Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci 28:57–87. https://doi.org/10.1146/annurev.neuro.28.061604.135718

Article  CAS  PubMed  Google Scholar 

Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A (2017) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol 155:171–193. https://doi.org/10.1016/j.pneurobio.2015.07.003

Article  CAS  PubMed  Google Scholar 

Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci 15(3):349–357. https://doi.org/10.1038/nn.3028

Article  CAS  PubMed  Google Scholar 

Castillo-Carranza DL, Gerson JE, Sengupta U, Guerrero-Munoz MJ, Lasagna-Reeves CA, Kayed R (2014) Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. J Alzheimers Dis 40(Suppl 1):S97–S111. https://doi.org/10.3233/JAD-132477

Article  CAS  PubMed  Google Scholar 

Cohen TJ, Lee VM, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17(11):659–667. https://doi.org/10.1016/j.molmed.2011.06.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ekimova IV, Plaksina DV, Pastukhov YF, Lapshina KV, Lazarev VF, Mikhaylova ER, Polonik SG, Pani B et al. (2018) New HSF1 inducer as a therapeutic agent in a rodent model of Parkinson’s disease. Exp Neurol 306:199–208. https://doi.org/10.1016/j.expneurol.2018.04.012

Article  CAS  PubMed  Google Scholar 

Buchberger A, Bukau B, Sommer T (2010) Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol Cell 40(2):238–252. https://doi.org/10.1016/j.molcel.2010.10.001

Article  CAS  PubMed  Google Scholar 

Neus Bosch M, Pugliese M, Andrade C, Gimeno-Bayon J, Mahy N, Rodriguez MJ (2015) Amyloid-beta immunotherapy reduces amyloid plaques and astroglial reaction in aged domestic dogs. Neurodegener Dis 15(1):24–37. https://doi.org/10.1159/000368672

Article  CAS  PubMed  Google Scholar 

Xing HY, Li B, Peng D, Wang CY, Wang GY, Li P, Le YY, Wang JM et al. (2017) A novel monoclonal antibody against the N-terminus of Abeta1-42 reduces plaques and improves cognition in a mouse model of Alzheimer’s disease. PLoS ONE 12(6):e0180076. https://doi.org/10.1371/journal.pone.0180076

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schenk DB, Koller M, Ness DK, Griffith SG, Grundman M, Zago W, Soto J, Atiee G, Ostrowitzki S, Kinney GG (2017) First-in-human assessment of PRX002, an anti-alpha-synuclein monoclonal antibody, in healthy volunteers. Mov Disord 32(2):211–218. https://doi.org/10.1002/mds.26878

Article  CAS  PubMed  Google Scholar 

Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J et al. (2019) Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol 19(1):20. https://doi.org/10.1186/s12883-019-1252-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qu J, Ren X, Xue F, He Y, Zhang R, Zheng Y, Huang H, Wang W et al. (2020) Specific knockdown of alpha-synuclein by peptide-directed proteasome degradation rescued its associated neurotoxicity. Cell Chem Biol 27(6):751-762 e754. https://doi.org/10.1016/j.chembiol.2020.03.010

Article  CAS  PubMed  Google Scholar 

McFarthing K, Simuni T (2019) Clinical trial highlights: targetting alpha-synuclein. J Parkinsons Dis 9(1):5–16. https://doi.org/10.3233/JPD-189004

Article  PubMed  Google Scholar 

Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N et al. (2018) Trial of solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med 378(4):321–330. https://doi.org/10.1056/NEJMoa1705971

Article  CAS  PubMed  Google Scholar 

Sweeney P, Park H, Baumann M, Dunlop J, Frydman J, Kopito R, McCampbell A, Leblanc G et al. (2017) Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener 6:6. https://doi.org/10.1186/s40035-017-0077-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gurry T, Stultz CM (2014) Mechanism of amyloid-beta fibril elongation. Biochemistry 53(44):6981–6991. https://doi.org/10.1021/bi500695g

Article  CAS  PubMed  Google Scholar 

Yang PH, Zhu JX, Huang YD, Zhang XY, Lei P, Bush AI, Xiang Q, Su ZJ et al. (2016) Human basic fibroblast growth factor inhibits tau phosphorylation via the PI3K/Akt-GSK3beta signaling pathway in a 6-hydroxydopamine-induced model of Parkinson’s disease. Neurodegener Dis 16(5–6):357–369. https://doi.org/10.1159/000445871

Article  CAS  PubMed  Google Scholar 

Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2(7):492–501. https://doi.org/10.1038/35081564

Article  CAS  PubMed  Google Scholar 

Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33(1):95–130. https://doi.org/10.1016/s0165-0173(00)00019-9

Article  CAS  PubMed  Google Scholar 

Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12(6):609–622. https://doi.org/10.1016/S1474-4422(13)70090-5

Article  CAS  PubMed  Google Scholar 

Sanghai N, Tranmer GK (2021) Hydrogen peroxide and amyotrophic lateral sclerosis: from biochemistry to pathophysiology. Antioxidants (Basel) 11 (1). https://doi.org/10.3390/antiox11010052

Koyuncu S, Fatima A, Gutierrez-Garcia R, Vilchez D (2017) Proteostasis of huntingtin in health and disease. Int J Mol Sci 18 (7). https://doi.org/10.3390/ijms18071568

Baldwin KJ, Correll CM (2019) Prion disease. Semin Neurol 39(4):428–439. https://doi.org/10.1055/s-0039-1687841

留言 (0)

沒有登入
gif